U.S. Celiac Disease Market to 2032
Overview
The U.S. Celiac Disease Market is expected to reach a 176.78 USD Million by 2032 and is projected to grow at a CAGR of 11.60% from 2025 to 2032.
Revenue, 2024 (USD Million)
87.15
Forecast, 2032 (USD Million)
176.78
CAGR, 2024 - 2032
11.60%
Report Coverage
U.S.
U.S. Celiac Disease Market 2018-2032 USD Million
U.S. Celiac Disease Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 87.15 USD Million
- Projected Market Size (2032): 176.78 USD Million
- CAGR (2025-2032): 11.60%
Key Findings of U.S. Celiac Disease Market
- The U.S. Celiac Disease Market was valued at 87.15 USD Million in 2024.
- The U.S. Celiac Disease Market is likely to grow at a CAGR of 11.60% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Prescription in Prescription Segment accounted for the largest share of the market with a revenue of 80.56 USD Million
- The fastest growing segment Adults in Population Segment grew Fastest with a CAGR of 12.55% during the forecast period from 2024 to 2032.
U.S. Celiac Disease Market Scope
U.S. Celiac Disease Market Segmentation & Scope
End User
- Hospitals
- Clinics
- Home Care Settings
- Others
Population
- Geriatric
- Children
- Adults
Route of Administration
- Topical
- Intravenous
- Oral
Distribution Channel
- Others
- Online Pharmacy
- Retail Pharmacy
- Hospital Pharmacy
Dosage Form
- Injections
- Capsules
- Tablet
- Others
Treatment
- Immunosuppressants
- Corticosteriods
- Others
Diseases
- Refractory Celiac Disease
- Non-Classical Celiac Disease
- Classical Celiac Disease
- Potential Celiac Disease
- Dermatitis Herpetiformis
Prescription
- Over The Counter
- Prescription
Drug
- Branded
- Generics
U.S. Celiac Disease Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 87.15 USD Million |
| Market Value in 2032 | 176.78 USD Million |
| CAGR (2025-2032) | 11.60% |
| Historic Data | 2016-2023 |
| Market Segments Covered | End User,Population,Route of Administration,Distribution Channel,Dosage Form,Treatment,Diseases,Prescription,Drug |
Regional Insights:
-
Leading Market (2024-2032): U.S., leading in terms of revenue 87.15 USD Million in 2024
- Key Country: U.S., leading in terms of revenue with value of 87.15 USD Million in 2024.
Segments and Scope
-
U.S. Celiac Disease Market to 2032, By End User
- Hospitals is the largest segment in U.S. Celiac Disease Market to 2032 with a revenue of 57.94 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in U.S. Celiac Disease Market to 2032 with a Growth rate of 12.12 % in forecast period 2025-2032.
-
U.S. Celiac Disease Market to 2032, By Population
- Adults is the largest segment in U.S. Celiac Disease Market to 2032 with a revenue of 51.80 USD Million in the year 2024.
- Adults is the Fastest growing segment in U.S. Celiac Disease Market to 2032 with a Growth rate of 12.55 % in forecast period 2025-2032.
-
U.S. Celiac Disease Market to 2032, By Route of Administration
- Oral is the largest segment in U.S. Celiac Disease Market to 2032 with a revenue of 65.26 USD Million in the year 2024.
- Oral is the Fastest growing segment in U.S. Celiac Disease Market to 2032 with a Growth rate of 12.14 % in forecast period 2025-2032.
-
U.S. Celiac Disease Market to 2032, By Distribution Channel
- Hospital Pharmacy is the largest segment in U.S. Celiac Disease Market to 2032 with a revenue of 57.82 USD Million in the year 2024.
- Hospital Pharmacy is the Fastest growing segment in U.S. Celiac Disease Market to 2032 with a Growth rate of 12.14 % in forecast period 2025-2032.
-
U.S. Celiac Disease Market to 2032, By Dosage Form
- Tablet is the largest segment in U.S. Celiac Disease Market to 2032 with a revenue of 66.14 USD Million in the year 2024.
- Tablet is the Fastest growing segment in U.S. Celiac Disease Market to 2032 with a Growth rate of 11.93 % in forecast period 2025-2032.
-
U.S. Celiac Disease Market to 2032, By Treatment
- Corticosteriods is the largest segment in U.S. Celiac Disease Market to 2032 with a revenue of 60.09 USD Million in the year 2024.
- Corticosteriods is the Fastest growing segment in U.S. Celiac Disease Market to 2032 with a Growth rate of 11.90 % in forecast period 2025-2032.
-
U.S. Celiac Disease Market to 2032, By Diseases
- Refractory Celiac Disease is the largest segment in U.S. Celiac Disease Market to 2032 with a revenue of 43.83 USD Million in the year 2024.
- Refractory Celiac Disease is the Fastest growing segment in U.S. Celiac Disease Market to 2032 with a Growth rate of 12.31 % in forecast period 2025-2032.
-
U.S. Celiac Disease Market to 2032, By Prescription
- Prescription is the largest segment in U.S. Celiac Disease Market to 2032 with a revenue of 80.56 USD Million in the year 2024.
- Prescription is the Fastest growing segment in U.S. Celiac Disease Market to 2032 with a Growth rate of 11.83 % in forecast period 2025-2032.
-
U.S. Celiac Disease Market to 2032, By Drug
- Generics is the largest segment in U.S. Celiac Disease Market to 2032 with a revenue of 69.02 USD Million in the year 2024.
- Generics is the Fastest growing segment in U.S. Celiac Disease Market to 2032 with a Growth rate of 11.73 % in forecast period 2025-2032.
U.S. Celiac Disease Market Company Share Analysis
U.S. Celiac Disease Market Geographical Sales Distribution, 2018-2032 USD Million
U.S. Celiac Disease Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The U.S. Celiac Disease Market is segmented based on Segmentation End User,Population,Route of Administration,Distribution Channel,Dosage Form,Treatment,Diseases,Prescription,Drug.
U.S. Celiac Disease Market was valued at USD 87.15(Revenue in USD Million) in 2022.
U.S. Celiac Disease Market is projected to grow at a CAGR of 11.60% during the forecast period of 2024 to 2032.
The Prescription segment is expected to dominate the U.S. Celiac Disease Market, holding a largest market share of 80.56 USD Million in 2024
U.S. Celiac Disease Market Scope
U.S. Celiac Disease Market Segmentation & Scope
End User
- Hospitals
- Clinics
- Home Care Settings
- Others
Population
- Geriatric
- Children
- Adults
Route of Administration
- Topical
- Intravenous
- Oral
Distribution Channel
- Others
- Online Pharmacy
- Retail Pharmacy
- Hospital Pharmacy
Dosage Form
- Injections
- Capsules
- Tablet
- Others
Treatment
- Immunosuppressants
- Corticosteriods
- Others
Diseases
- Refractory Celiac Disease
- Non-Classical Celiac Disease
- Classical Celiac Disease
- Potential Celiac Disease
- Dermatitis Herpetiformis
Prescription
- Over The Counter
- Prescription
Drug
- Branded
- Generics
Frequently Asked Questions
The U.S. Celiac Disease Market is segmented based on Segmentation End User,Population,Route of Administration,Distribution Channel,Dosage Form,Treatment,Diseases,Prescription,Drug.
U.S. Celiac Disease Market was valued at USD 87.15(Revenue in USD Million) in 2022.
U.S. Celiac Disease Market is projected to grow at a CAGR of 11.60% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Celiac Disease Market for final year is USD 176.78 (USD Million).
U.S. Celiac Disease Market Company Profiling
Frequently Asked Questions
The U.S. Celiac Disease Market is segmented based on Segmentation End User,Population,Route of Administration,Distribution Channel,Dosage Form,Treatment,Diseases,Prescription,Drug.
U.S. Celiac Disease Market was valued at USD 87.15(Revenue in USD Million) in 2022.
U.S. Celiac Disease Market is projected to grow at a CAGR of 11.60% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Celiac Disease Market for final year is USD 176.78 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.